Literature DB >> 17261613

Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.

Peggy C R Godschalk1, Mark L Kuijf, Jianjun Li, Frank St Michael, C Wim Ang, Bart C Jacobs, Marie-France Karwaski, Denis Brochu, Ali Moterassed, Hubert P Endtz, Alex van Belkum, Michel Gilbert.   

Abstract

Molecular mimicry between lipooligosaccharides (LOS) of Campylobacter jejuni and gangliosides in peripheral nerves plays a crucial role in the pathogenesis of C. jejuni-related Guillain-Barré syndrome (GBS). We have analyzed the LOS outer core structures of 26 C. jejuni strains associated with GBS and its variant, Miller Fisher syndrome (MFS), by capillary electrophoresis coupled with electrospray ionization mass spectrometry. Sixteen out of 22 (73%) GBS-associated and all 4 (100%) MFS-associated strains expressed LOS with ganglioside mimics. GM1a was the most prevalent ganglioside mimic in GBS-associated strains (10/22, 45%), and in eight of these strains, GM1a was found in combination with GD1a mimics. All seven strains isolated from patients with ophthalmoplegia (GBS or MFS) expressed disialylated (GD3 or GD1c) mimics. Three out of 22 GBS-associated strains (14%) did not express sialylated ganglioside mimics because their LOS locus lacked the genes necessary for sialylation. Three other strains (14%) did not express ganglioside mimics because of frameshift mutations in either the cstII sialyltransferase gene or the cgtB galactosyltransferase gene. It is not possible to determine if these mutations were already present during C. jejuni infection. This is the first report in which mass spectrometry combined with DNA sequence data were used to infer the LOS outer core structures of a large number of neuropathy-associated C. jejuni strains. We conclude that molecular mimicry between gangliosides and C. jejuni LOS is the presumable pathogenic mechanism in most cases of C. jejuni-related GBS. However, our findings suggest that in some cases, other mechanisms may play a role. Further examination of the disease etiology in these patients is mandatory.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261613      PMCID: PMC1828588          DOI: 10.1128/IAI.00872-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  A Campylobacter jejuni gene associated with immune-mediated neuropathy.

Authors:  A van Belkum; N van den Braak; P Godschalk; W Ang; B Jacobs; M Gilbert; W Wakarchuk; H Verbrugh; H Endtz
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

2.  Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.

Authors:  H P Endtz; C W Ang; N van Den Braak; B Duim; A Rigter; L J Price; D L Woodward; F G Rodgers; W M Johnson; J A Wagenaar; B C Jacobs; H A Verbrugh; A van Belkum
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide.

Authors:  Michel Gilbert; Marie-France Karwaski; Stéphane Bernatchez; N Martin Young; Eduardo Taboada; Joseph Michniewicz; Anna-Maria Cunningham; Warren W Wakarchuk
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

4.  Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.

Authors:  Peggy C R Godschalk; Michel Gilbert; Bart C Jacobs; Tessely Kramers; Anne P Tio-Gillen; C Wim Ang; Nicole Van den Braak; Jianjun Li; Henri A Verbrugh; Alex Van Belkum; Hubert P Endtz
Journal:  Microbes Infect       Date:  2005-09-13       Impact factor: 2.700

5.  Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barré and Miller-Fisher syndromes are of diverse genetic lineage, serotype, and flagella type.

Authors:  K E Dingle; N Van Den Braak; F M Colles; L J Price; D L Woodward; F G Rodgers; H P Endtz; A Van Belkum; M C Maiden
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.

Authors:  Michiaki Koga; Michel Gilbert; Masaki Takahashi; Jianjun Li; Saiko Koike; Koichi Hirata; Nobuhiro Yuki
Journal:  J Infect Dis       Date:  2006-01-19       Impact factor: 5.226

7.  A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis.

Authors:  C W Ang; P A van Doorn; H P Endtz; I S Merkies; B C Jacobs; M A de Klerk; R van Koningsveld; F G van der Meché
Journal:  J Neuroimmunol       Date:  2000-11-01       Impact factor: 3.478

Review 8.  Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.

Authors:  N Yuki
Journal:  Lancet Infect Dis       Date:  2001-08       Impact factor: 25.071

9.  Anti-ganglioside complex antibodies in Miller Fisher syndrome.

Authors:  K Kaida; M Kanzaki; D Morita; K Kamakura; K Motoyoshi; M Hirakawa; S Kusunoki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-13       Impact factor: 10.154

10.  Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Authors:  C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

View more
  52 in total

1.  Campylobacter jejuni translocation across intestinal epithelial cells is facilitated by ganglioside-like lipooligosaccharide structures.

Authors:  Rogier Louwen; Edward E S Nieuwenhuis; Leonie van Marrewijk; Deborah Horst-Kreft; Lilian de Ruiter; Astrid P Heikema; Willem J B van Wamel; Jaap A Wagenaar; Hubert P Endtz; Janneke Samsom; Peter van Baarlen; Anna Akhmanova; Alex van Belkum
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 2.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

Review 3.  Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infections.

Authors:  Adrienne W Paton; Renato Morona; James C Paton
Journal:  Bioeng Bugs       Date:  2009-11-17

4.  Biosynthesis of GDP-d-glycero-α-d-manno-heptose for the Capsular Polysaccharide of Campylobacter jejuni.

Authors:  Jamison P Huddleston; Frank M Raushel
Journal:  Biochemistry       Date:  2019-08-29       Impact factor: 3.162

5.  Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

6.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

7.  Enhanced, sialoadhesin-dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages.

Authors:  Astrid P Heikema; Roman I Koning; Sharon Duarte dos Santos Rico; Hans Rempel; Bart C Jacobs; Hubert P Endtz; Willem J B van Wamel; Janneke N Samsom
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

Review 8.  The interplay between Siglecs and sialylated pathogens.

Authors:  Yung-Chi Chang; Victor Nizet
Journal:  Glycobiology       Date:  2014-07-04       Impact factor: 4.313

9.  Can Campylobacter coli induce Guillain-Barré syndrome?

Authors:  A van Belkum; B Jacobs; E van Beek; R Louwen; W van Rijs; L Debruyne; M Gilbert; J Li; A Jansz; F Mégraud; H Endtz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-12       Impact factor: 3.267

10.  Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh.

Authors:  Zhahirul Islam; Alex van Belkum; Jaap A Wagenaar; Alison J Cody; Albert G de Boer; Helen Tabor; Bart C Jacobs; Kaisar A Talukder; Hubert P Endtz
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.